SLILATY STEVE N. (Chief Executive Officer) received a stock award from SUNSHINE BIOPHARMA INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/25/2020ACC: 0001128732-20-000002
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+500K
Net shares
Net buyer
$50.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
500K acquired
Non-Derivative Transactions1
Series "B" Preferred Stock
Direct
Shares
+500K
Price / share
$0.10
Trade value
$50K
% of position
100.0%
6/17/2020
500K→1M
Total
Net shares
+500K
Net value
$50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series "B" Preferred Stock Direct | 6/17/2020 | A · Award | +500K | $0.10 | $50K | 100.0% | 500K | 1M |
| Total | +500K | $50K | ||||||
Derivative Transactions0
No derivative transactions reported